Company Valuation: Kwality Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 581.1 6,018 3,191 4,248 9,017 13,555
Change - 935.71% -46.97% 33.12% 112.27% 50.32%
Enterprise Value (EV) 1 890.9 6,429 4,020 5,170 9,994 14,826
Change - 621.62% -37.47% 28.59% 93.32% 48.34%
P/E 3.84x 5.02x 16.5x 17.9x 22.6x 20.1x
PBR 0.95x 3.32x 1.59x 1.89x 3.42x 4.09x
PEG - 0x -0.2x 0.8x 0.3x 0.3x
Capitalization / Revenue 0.22x 1.31x 1.27x 1.38x 2.44x 2.69x
EV / Revenue 0.34x 1.4x 1.6x 1.68x 2.7x 2.95x
EV / EBITDA 2.95x 3.71x 6.52x 7.6x 12.2x 12.3x
EV / EBIT 3.76x 3.95x 8.61x 10.7x 15.7x 14.8x
EV / FCF -31x -28.5x -15.5x -39.5x -155x -27.5x
FCF Yield -3.22% -3.51% -6.43% -2.53% -0.64% -3.64%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 14.6 115.6 18.67 22.93 38.4 64.9
Distribution rate - - - - - -
Net sales 1 2,631 4,579 2,510 3,072 3,702 5,031
EBITDA 1 301.8 1,735 616.4 680.1 820.4 1,203
EBIT 1 236.9 1,628 466.8 484.5 637.5 1,005
Net income 1 151.5 1,200 193.7 238 398.5 673.5
Net Debt 1 309.8 410.6 829 921.8 976.9 1,271
Reference price 2 56.00 580.00 307.55 409.40 869.05 1,306.35
Nbr of stocks (in thousands) 10,376 10,376 10,376 10,376 10,376 10,376
Announcement Date 07/09/21 07/09/22 08/09/23 31/08/24 18/08/25 09/08/26
1INR in Million2INR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 386M
37.06x13.1x27.8x0.54% 1,135B
38.61x6.49x18.27x2.02% 635B
36.46x8.38x17.29x2.41% 505B
20.87x5.11x12.73x2.56% 378B
105.89x5.92x25.41x2.34% 358B
21.76x5.68x13.94x2.81% 295B
22.43x4.53x12.94x1.95% 266B
27.87x7.16x12.81x2.3% 237B
-45.48x6.98x27.06x2.11% 193B
Average 29.50x 7.04x 18.69x 2.12% 400.4B
Weighted average by Cap. 35.23x 8.29x 20.39x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Kwality Pharmaceuticals Limited

Historical PBR trend

Valuation ratios - PBR - Kwality Pharmaceuticals Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Kwality Pharmaceuticals Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Kwality Pharmaceuticals Limited

  1. Stock Market
  2. Stocks
  3. KPL Stock
  4. Valuation Kwality Pharmaceuticals Limited